Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeinab Gharaylou

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Neuroreport|March 1, 2019
Brain microstructural abnormalities correlate with KCC2 downregulation in refractory epilepsyZeinab Gharaylou, Mohammad A Oghabian, Zahra Azizi, et al.
Applied Neuropsychology. Child|December 3, 2021
Long-term bumetanide administration altered behavioral pattern in mosaic Down's Syndrome: A case reportZeinab Gharaylou, Lida Shafaghi, Seyed Khalil Pestehei, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 23, 2013
Pre-pubertal castration improves spatial learning during mid-adolescence in ratsFarshad Moradpour, Nasser Naghdi, Yaghoub Fathollahi, et al.
Translational Neuroscience|July 9, 2024
Comorbidity in spinal cord injury in Iran: A narrative reviewTaher Taheri, Saereh Hosseindoost, Hadi Kazemi, et al.
CNS Drugs|February 21, 2019
A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients with Drug-Resistant EpilepsyZeinab Gharaylou, Abbas Tafakhori, Elmira Agah, et al.
CNS Drugs|July 25, 2019
Correction to: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients with Drug-Resistant EpilepsyZeinab Gharaylou, Abbas Tafakhori, Elmira Agah, et al.
Basic and Clinical Neuroscience|December 17, 2021
Analgesic Effect of Bumetanide on Neuropathic Pain in Patients With Spinal Cord InjuryFarinaz Nasirinezhad, Leila Zarepour, Mahmoudreza Hadjighassem, et al.
Brain Connectivity|February 3, 2024
Reduced White Matter Fiber Density in Patients with Multiple SclerosisZeinab Gharaylou, Fatemeh Shahbodaghy, Pirhossein Kolivand, et al.
Brain Research Bulletin|November 16, 2023
Symmetry differences of structural connectivity in multiple sclerosis and healthy stateFatemeh Shahbodaghy, Lida Shafaghi, Massoumeh Rostampour, et al.
Frontiers in Pharmacology|November 7, 2022
Long-term administration of bumetanide improve functional recovery after spinal cord injury in ratsShiva Hashemizadeh, Zeinab Gharaylou, Saereh Hosseindoost, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Neuroreport|March 1, 2019
Brain microstructural abnormalities correlate with KCC2 downregulation in refractory epilepsyZeinab Gharaylou, Mohammad A Oghabian, Zahra Azizi, et al.
Applied Neuropsychology. Child|December 3, 2021
Long-term bumetanide administration altered behavioral pattern in mosaic Down's Syndrome: A case reportZeinab Gharaylou, Lida Shafaghi, Seyed Khalil Pestehei, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 23, 2013
Pre-pubertal castration improves spatial learning during mid-adolescence in ratsFarshad Moradpour, Nasser Naghdi, Yaghoub Fathollahi, et al.
Translational Neuroscience|July 9, 2024
Comorbidity in spinal cord injury in Iran: A narrative reviewTaher Taheri, Saereh Hosseindoost, Hadi Kazemi, et al.
CNS Drugs|February 21, 2019
A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients with Drug-Resistant EpilepsyZeinab Gharaylou, Abbas Tafakhori, Elmira Agah, et al.
CNS Drugs|July 25, 2019
Correction to: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients with Drug-Resistant EpilepsyZeinab Gharaylou, Abbas Tafakhori, Elmira Agah, et al.
Basic and Clinical Neuroscience|December 17, 2021
Analgesic Effect of Bumetanide on Neuropathic Pain in Patients With Spinal Cord InjuryFarinaz Nasirinezhad, Leila Zarepour, Mahmoudreza Hadjighassem, et al.
Brain Connectivity|February 3, 2024
Reduced White Matter Fiber Density in Patients with Multiple SclerosisZeinab Gharaylou, Fatemeh Shahbodaghy, Pirhossein Kolivand, et al.
Brain Research Bulletin|November 16, 2023
Symmetry differences of structural connectivity in multiple sclerosis and healthy stateFatemeh Shahbodaghy, Lida Shafaghi, Massoumeh Rostampour, et al.
Frontiers in Pharmacology|November 7, 2022
Long-term administration of bumetanide improve functional recovery after spinal cord injury in ratsShiva Hashemizadeh, Zeinab Gharaylou, Saereh Hosseindoost, et al.
Pageof 2